Start for free
Start for free
Canadian Medical Discoveries Fund logo

Canadian Medical Discoveries Fund

North America, Nova Scotia, Canada, Halifax

Description

Founded in 1994, Canadian Medical Discoveries Fund invests in the life sciences sector and is a labor-sponsored investment fund.

Investor Profile

Canadian Medical Discoveries Fund has made 12 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (42%)
  • Series B (25%)
  • Series A (17%)
  • Series D (8%)
  • Private Equity (8%)

Country Focus

  • Canada (67%)
  • United States (33%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Clinical Trials
  • Health Care
  • Medical
  • Biopharma
  • Therapeutics
  • Manufacturing
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Canadian Medical Discoveries Fund frequently co-invest with?

BDC Capital Corporation
BDC Capital Corporation
North America, Massachusetts, United States, Wakefield
Co-Investments: 2
Morningside Group
Morningside Group
North America, Massachusetts, United States, Newton Center
Co-Investments: 2
BDC Venture Capital
BDC Venture Capital
North America, Alberta, Canada, Calgary
Co-Investments: 3
GrowthWorks Capital
GrowthWorks Capital
North America, British Columbia, Canada, Vancouver
Co-Investments: 3
Business Development Bank of Canada
Business Development Bank of Canada
North America, Quebec, Canada, Montréal
Co-Investments: 3
Novo Holdings
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 4
Caisse de Depot et Placement du Quebec
Caisse de Depot et Placement du Quebec
North America, Quebec, Canada, Montréal
Co-Investments: 2
VentureLink LP
VentureLink LP
North America, Ontario, Canada, Toronto
Co-Investments: 3
GeneChem
GeneChem
North America, Quebec, Canada, Montréal
Co-Investments: 6
Roche Venture Fund
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 2

What are some of recent deals done by Canadian Medical Discoveries Fund?

Cytochroma

Kingston, Ontario, Canada

Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat

BiotechnologyClinical TrialsPharmaceutical
Series CJul 30, 2008
Amount Raised: $43,960,810
Gemin X Pharmaceuticals

Montréal, Quebec, Canada

Gemin X Pharmaceuticals develops and commercializes targeted cancer therapeutics to improve the lives of patients.

BiotechnologyPharmaceuticalTherapeutics
Series CJul 3, 2008
Amount Raised: $38,000,000
Inimex Pharmaceuticals

Burnaby, British Columbia, Canada

Inimex Pharmaceuticals is a clinical-stage company focused on the development and commercialization of innate defense regulators.

BiotechnologyMedicalPharmaceutical
Series BJun 2, 2008
Amount Raised: $22,000,000
ViOptix

Fremont, California, United States

ViOptix, a biotech company, manufactures innovative proprietary products for tissue oximetry–measuring oxygen saturation levels in tissues.

BiotechnologyHealth CareManufacturing
Series DJan 10, 2008
Amount Raised: $12,200,000
Targanta Therapeutics

Cambridge, Massachusetts, United States

Targanta Therapeutics is a biopharma Company

BiopharmaHealth CarePharmaceutical
Series CFeb 8, 2007
Amount Raised: $70,000,000
Cytochroma

Kingston, Ontario, Canada

Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat

BiotechnologyClinical TrialsPharmaceutical
Series CJan 18, 2007
Amount Raised: $17,873,314
Ambit Biosciences

San Diego, California, United States

Ambit Biosciences, a biopharmaceutical company, develops small molecule kinase inhibitors for cancer and inflammatory disease treatments.

BiopharmaBiotechnologyHealth Care
Series CMay 12, 2005
Amount Raised: $31,000,000
Inimex Pharmaceuticals

Burnaby, British Columbia, Canada

Inimex Pharmaceuticals is a clinical-stage company focused on the development and commercialization of innate defense regulators.

BiotechnologyMedicalPharmaceutical
Series ADec 8, 2004
Amount Raised: $1,635,181
PhageTech

Irvine, California, United States

PhageTech develops bio conducting materials that offers its users with advantages of immediacy, accessibility, and robustness.

Health CareMedicalMedical Device
Private EquityJan 30, 2002
Amount Raised: $10,000,000
Cytochroma

Kingston, Ontario, Canada

Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat

BiotechnologyClinical TrialsPharmaceutical
Series BDec 18, 2001
Amount Raised: $2,226,803
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator